Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Vaxcyte (PCVX)

Vaxcyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PCVX
DateTimeSourceHeadlineSymbolCompany
07/03/202521:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
05/03/202521:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
04/03/202502:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
04/03/202502:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
04/03/202502:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
04/03/202502:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
03/03/202521:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
25/02/202521:42Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PCVXVaxcyte Inc
25/02/202521:11Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PCVXVaxcyte Inc
25/02/202521:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCVXVaxcyte Inc
25/02/202521:01GlobeNewswire Inc.Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateNASDAQ:PCVXVaxcyte Inc
12/02/202521:05GlobeNewswire Inc.Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025NASDAQ:PCVXVaxcyte Inc
07/02/202521:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
05/02/202521:01Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
05/02/202513:00GlobeNewswire Inc.Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in InfantsNASDAQ:PCVXVaxcyte Inc
05/02/202500:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
03/02/202521:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
30/01/202521:05GlobeNewswire Inc.Vaxcyte to Present at the Guggenheim SMID Cap Biotech ConferenceNASDAQ:PCVXVaxcyte Inc
17/01/202521:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
15/01/202521:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
07/01/202521:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
07/01/202506:13PR Newswire (US)Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law FirmNASDAQ:PCVXVaxcyte Inc
06/01/202521:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
03/01/202523:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
02/01/202521:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
18/12/202421:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
09/12/202423:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
05/12/202421:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
04/12/202400:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
03/12/202413:00GlobeNewswire Inc.Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in InfantsNASDAQ:PCVXVaxcyte Inc
 Showing the most relevant articles for your search:NASDAQ:PCVX